Oncopeptides will host a webcast on Monday, January 27[th] at 11.00 (CET)
STOCKHOLM — January 24, 2020 — Oncopeptides AB (Nasdaq Stockholm: ONCO) announces today that it will host a webcast at 11am (CET) on Monday, January 27[th] 2020 where CEO Jakob Lindberg will present and explain melflufen’s mechanism of action.Conference call for investors, analysts and the media, Monday, January 27[th] 2020, at 11 (CET). Phone numbers for participants from: Sweden: +46 8 505 58 352Europe: +44 3333 009 262USA: +1 833 526 8347 The conference call will also be streamed on the corporate website www.oncopeptides.com and via the link below. https://tv.